Accessibility Menu
 
Alzamend Neuro logo

Alzamend Neuro

(NASDAQ) ALZN

Current Price$0.98
Market Cap$3.80M
Since IPO (2021)-100%
5 YearN/A
1 Year-89%
1 Month-47%

Alzamend Neuro Financials at a Glance

Market Cap

$3.80M

Revenue (TTM)

$0.00

Net Income (TTM)

$7.04M

EPS (TTM)

$-4.38

P/E Ratio

-0.23

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.98

Volume

805

Open

$1.01

Previous Close

$0.98

Daily Range

$0.98 - $1.02

52-Week Range

$0.98 - $9.45

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alzamend Neuro

Industry

Biotechnology

Employees

6

CEO

Stephan Jackman

Headquarters

Atlanta, GA 30326, US

ALZN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-250%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-4.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.80M

Shares Outstanding

3.80M

Volume

805

Short Interest

0.00%

Avg. Volume

142.39K

Financials (TTM)

Gross Profit

$50.74K

Operating Income

$4.50M

EBITDA

$4.45M

Operating Cash Flow

$6.57M

Capital Expenditure

$300.00K

Free Cash Flow

$6.87M

Cash & ST Invst.

$3.95M

Total Debt

$0.00

Alzamend Neuro Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$27.68K

-118.2%

Gross Margin

0.00%

N/A

Market Cap

$3.80M

N/A

Market Cap/Employee

$951.10K

N/A

Employees

4

N/A

Net Income

$2.20M

-111.6%

EBITDA

$2.17M

-111.7%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$2.71M

-19.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.74%

N/A

Return on Invested Capital

-3.22%

N/A

Free Cash Flow

$1.74M

-22.0%

Operating Cash Flow

$1.74M

-22.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CDIOCardio Diagnostics Holdings, Inc.
$2.04+0.00%
APREAprea Therapeutics, Inc.
$0.72+1.65%
CELZCreative Medical Technology Holdings, Inc.
$2.05+3.19%
ACXPAcurx Pharmaceuticals, Inc.
$3.68-5.40%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.02%

Questions About ALZN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.